Digirad tumbles on class-action investigation

• What looks like a fairly typical hunting expedition by a class-action law firm is enough to send thinly-traded Digirad (DRAD -10.1%) sharply lower.
• A prescient bull on the stock, Seeking Alpha contributor Dane Capital Management isn't concerned, and sees the selloff as a buying opportunity. Even better, there's a positive catalyst looming as management hopes to close its "highly accretive" DMS Health acquisition prior to year-end. With a week to go, Dane is confident management will deliver.
• Previously: Digirad acquisition excites a bull (Oct. 14)